Exemed Pharmaceuticals, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is ALLOPURINOL USP, with a corresponding US DMF Number 36113.
Remarkably, this DMF maintains an Active status since its submission on July 13, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 26, 2022, and payment made on May 19, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II